8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 28, 2026·SEC
Material company update
Apr 7, 2026·SEC
Accuray Incorporated(ARAY)Earnings, Financials & Key Ratios
ARAY•NASDAQ
Price updated Jun 19, 2026
AboutAccuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.Show more
- Revenue$459M+2.7%
- EBITDA$14M+118.3%
- Net Income-$2M+89.8%
- EPS (Diluted)-0.02+90.3%
- Gross Margin32.05%+0.1%
- EBITDA Margin3.05%+112.6%
- Operating Margin1.71%+1414.3%
- Net Margin-0.35%+90.0%
- ROE-2.52%+92.0%
ARAY Key Insights
Accuray Incorporated (ARAY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.4x book value
✗Weaknesses
- ✗High debt to equity ratio of 2.2x
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 7 (bottom 7%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ARAY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ARAY Price & Volume
Accuray Incorporated (ARAY) stock price & volume — 10-year historical chart
Loading chart...
ARAY Growth Metrics
Accuray Incorporated (ARAY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years1.9%
5 Years3.67%
3 Years2.17%
TTM-7.88%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-6954.38%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-6366.1%
Return on Capital
10 Years0.53%
5 Years2.86%
3 Years1.3%
Last Year2.85%
ARAY Recent Earnings
Accuray Incorporated (ARAY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.09-80.0%
$0.05
Rev
$105M-6.3%
$112M
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$0.11-2.2%
$0.11
Rev
$102M+1.4%
$101M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.18-1700.0%
$0.01
Rev
$94M-23.6%
$123M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.01-65.6%
$0.03
Rev
$128M+37.2%
$93M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.09vs $0.05-80.0% | $105Mvs $112M-6.3% |
| Q1 2026 | Feb 4, 2026 | $0.11vs $0.11-2.2% | $102Mvs $101M+1.4% |
| Q4 2025 | Nov 5, 2025 | $0.18vs $0.01-1700.0% | $94Mvs $123M-23.6% |
| Q3 2025 | Aug 13, 2025 | $0.01vs $0.03-65.6% | $128Mvs $93M+37.2% |
Based on last 12 quarters of dataView full earnings history →
ARAY Peer Comparison
Accuray Incorporated (ARAY) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 | |
 GKOS | 7.65B | 130.68 | -39.84 | 32.33% | -34.34% | -26.46% | 0.21 | |
 GEHC | 28.02B | 61.59 | 13.54 | 4.84% | 7.54% | 14.45% | 0.94 |
Compare ARAY vs Peers
Accuray Incorporated (ARAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ARAY Income Statement
Accuray Incorporated (ARAY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 383.41M | 404.9M | 418.79M | 382.93M | 396.29M | 429.91M | 447.61M | 446.55M | 458.5M | 428.57M |
Revenue Growth % | -3.86% | 5.6% | 3.43% | -8.56% | 3.49% | 8.48% | 4.12% | -0.24% | 2.68% | -7.88% |
Cost of Goods Sold | 242.07M | 243.2M | 256.13M | 233.21M | 236.78M | 269.95M | 293.64M | 303.63M | 311.54M | 313.68M |
COGS % of Revenue | 63.14% | 60.07% | 61.16% | 60.9% | 59.75% | 62.79% | 65.6% | 67.99% | 67.95% | - |
Gross Profit | 141.34M▲ 0% | 161.69M▲ 14.4% | 162.65M▲ 0.6% | 149.72M▼ 7.9% | 159.51M▲ 6.5% | 159.96M▲ 0.3% | 153.96M▼ 3.7% | 142.92M▼ 7.2% | 146.97M▲ 2.8% | 114.89M▲ 0% |
Gross Margin % | 36.86% | 39.93% | 38.84% | 39.1% | 40.25% | 37.21% | 34.4% | 32.01% | 32.05% | 26.81% |
Gross Profit Growth % | -10.95% | 14.4% | 0.59% | -7.95% | 6.54% | 0.28% | -3.75% | -7.17% | 2.83% | - |
Operating Expenses | 151.16M | 165.49M | 162.07M | 137.18M | 137.27M | 151.81M | 151.58M | 142.42M | 139.13M | 130.01M |
OpEx % of Revenue | 39.43% | 40.87% | 38.7% | 35.82% | 34.64% | 35.31% | 33.86% | 31.89% | 30.34% | - |
Selling, General & Admin | 101.24M | 108.24M | 105.58M | 87.4M | 84.54M | 94.06M | 94.45M | 92.69M | 91.19M | 88.34M |
SG&A % of Revenue | 26.41% | 26.73% | 25.21% | 22.82% | 21.33% | 21.88% | 21.1% | 20.76% | 19.89% | - |
Research & Development | 49.92M | 57.25M | 56.49M | 49.78M | 52.73M | 57.75M | 57.13M | 49.73M | 47.94M | 41.67M |
R&D % of Revenue | 13.02% | 14.14% | 13.49% | 13% | 13.31% | 13.43% | 12.76% | 11.14% | 10.46% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.82M▲ 0% | -3.8M▲ 61.3% | -9.91M▼ 160.9% | 12.54M▲ 226.6% | 22.23M▲ 77.3% | 8.15M▼ 63.4% | 2.38M▼ 70.8% | 504K▼ 78.8% | 7.84M▲ 1455.4% | -15.12M▲ 0% |
Operating Margin % | -2.56% | -0.94% | -2.37% | 3.27% | 5.61% | 1.9% | 0.53% | 0.11% | 1.71% | -3.53% |
Operating Income Growth % | -101.58% | 61.35% | -160.94% | 226.55% | 77.33% | -63.36% | -70.77% | -78.84% | 1455.36% | - |
EBITDA | 8.18M | 5.93M | 583K | 20.08M | 28.62M | 13.66M | 6.91M | 6.41M | 13.99M | -6.4M |
EBITDA Margin % | 2.13% | 1.47% | 0.14% | 5.24% | 7.22% | 3.18% | 1.54% | 1.44% | 3.05% | -1.49% |
EBITDA Growth % | -39.08% | -27.42% | -90.18% | 3344.25% | 42.55% | -52.27% | -49.43% | -7.24% | 118.27% | -138.83% |
D&A (Non-Cash Add-back) | 18M | 9.73M | 10.49M | 7.54M | 6.39M | 5.51M | 4.53M | 5.91M | 6.15M | 8.72M |
EBIT | -11.24M | -8.06M | 583K | 23.77M | 12.33M | 6.13M | 3.84M | -196K | 14.09M | -15.24M |
Net Interest Income | -17.3M | -14.96M | -15.08M | -18.08M | -16.89M | -8.13M | -10.63M | -11.62M | -11.76M | -27.69M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.19M | 742K |
Interest Expense | 17.3M | 14.96M | 15.08M | 18.08M | 16.89M | 8.13M | 10.63M | 11.62M | 12.95M | 28.43M |
Other Income/Expense | -18.72M | -19.22M | -14.93M | -6.85M | -26.79M | -10.15M | -9.17M | -12.32M | -6.71M | -28.55M |
Pretax Income | -28.54M▲ 0% | -23.02M▲ 19.3% | -14.34M▲ 37.7% | 5.69M▲ 139.7% | -4.56M▼ 180.1% | -2M▲ 56.1% | -6.79M▼ 239.1% | -11.82M▼ 74.1% | 1.13M▲ 109.6% | -43.67M▲ 0% |
Pretax Margin % | -7.44% | -5.69% | -3.43% | 1.49% | -1.15% | -0.47% | -1.52% | -2.65% | 0.25% | -10.19% |
Income Tax | 1.04M | 878K | 2.09M | 1.86M | 1.75M | 3.35M | 2.49M | 3.73M | 2.73M | 2.46M |
Effective Tax Rate % | -3.64% | -3.81% | -14.54% | 32.74% | -38.43% | -167.08% | -36.71% | -31.51% | 240.3% | -5.63% |
Net Income | -29.58M▲ 0% | -23.9M▲ 19.2% | -16.43M▲ 31.3% | 3.83M▲ 123.3% | -6.31M▼ 264.9% | -5.35M▲ 15.3% | -9.28M▼ 73.6% | -15.54M▼ 67.5% | -1.59M▲ 89.8% | -46.13M▲ 0% |
Net Margin % | -7.71% | -5.9% | -3.92% | 1% | -1.59% | -1.24% | -2.07% | -3.48% | -0.35% | -10.76% |
Net Income Growth % | -15.98% | 19.2% | 31.25% | 123.29% | -264.91% | 15.27% | -73.56% | -67.51% | 89.77% | -6954.38% |
Net Income (Continuing) | -29.58M | -23.9M | -16.43M | 3.83M | -6.31M | -5.35M | -9.28M | -15.54M | -1.59M | -46.13M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.36▲ 0% | -0.28▲ 22.2% | -0.19▲ 32.1% | 0.04▲ 122.2% | -0.07▼ 262.6% | -0.06▲ 15.3% | -0.10▼ 68.3% | -0.16▼ 63.6% | -0.02▲ 90.3% | -0.37▲ 0% |
EPS Growth % | -12.5% | 22.22% | 32.14% | 122.21% | -262.56% | 15.31% | -68.33% | -63.6% | 90.31% | -6366.1% |
EPS (Basic) | -0.36 | -0.28 | -0.19 | 0.04 | -0.07 | -0.06 | -0.10 | -0.16 | -0.02 | - |
Diluted Shares Outstanding | 82.5M | 84.89M | 87.47M | 90.62M | 92.03M | 92.09M | 94.88M | 98.27M | 102.77M | 124.3M |
Basic Shares Outstanding | 82.5M | 84.89M | 87.47M | 89.87M | 92.03M | 92.09M | 94.88M | 98.27M | 102.77M | 124.3M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ARAY Balance Sheet
Accuray Incorporated (ARAY) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 309M | 284.16M | 344.07M | 357.49M | 352.77M | 350.89M | 338.03M | 323.24M | 317.46M | 293.22M |
Cash & Short-Term Investments | 95.99M | 83.08M | 76.8M | 107.58M | 116.37M | 88.74M | 89.4M | 68.57M | 57.42M | 38.07M |
Cash Only | 72.08M | 83.08M | 76.8M | 107.58M | 116.37M | 88.74M | 89.4M | 68.57M | 57.42M | 38.07M |
Short-Term Investments | 23.91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 72.79M | 65.99M | 111.89M | 90.6M | 85.36M | 101.5M | 87.3M | 98.86M | 97.87M | 64.57M |
Days Sales Outstanding | 69.29 | 59.49 | 97.52 | 86.36 | 78.62 | 86.18 | 71.18 | 80.8 | 77.91 | 60.64 |
Inventory | 105.05M | 108.54M | 120.82M | 134.37M | 125.93M | 142.25M | 145.15M | 138.32M | 141.02M | 156.63M |
Days Inventory Outstanding | 158.4 | 162.9 | 172.18 | 210.31 | 194.12 | 192.34 | 180.42 | 166.28 | 165.22 | 175.74 |
Other Current Assets | 16.18M | 10.97M | 10.72M | 3.71M | 4.08M | 6.83M | 4.56M | 7.18M | 11.21M | 33.95M |
Total Non-Current Assets | 97.46M | 94.57M | 94.11M | 133.44M | 127.33M | 121.96M | 141.18M | 145.39M | 152.77M | 154.39M |
Property, Plant & Equipment | 23.06M | 23.7M | 17.12M | 44M | 34.85M | 29.48M | 46.78M | 58.55M | 61.77M | 57.9M |
Fixed Asset Turnover | 16.63x | 17.09x | 24.46x | 8.70x | 11.37x | 14.58x | 9.57x | 7.63x | 7.42x | 7.12x |
Goodwill | 57.81M | 57.85M | 57.77M | 57.72M | 57.96M | 57.84M | 57.68M | 57.67M | 57.8M | 57.88M |
Intangible Assets | 964K | 821K | 679K | 663K | 435K | 250K | 210K | 59K | 15K | 0 |
Long-Term Investments | 7.75M | 7.51M | 5.43M | 13.93M | 15.94M | 13.88M | 15.13M | 9.83M | 4.61M | 28.57M |
Other Non-Current Assets | 15.62M | 12.2M | 18.54M | 17.14M | 18.14M | 20.51M | 21.38M | 18.63M | 27.82M | 38.6M |
Total Assets | 406.46M▲ 0% | 378.73M▼ 6.8% | 438.18M▲ 15.7% | 490.93M▲ 12.0% | 480.1M▼ 2.2% | 472.85M▼ 1.5% | 479.21M▲ 1.3% | 468.63M▼ 2.2% | 470.24M▲ 0.3% | 447.6M▲ 0% |
Asset Turnover | 0.94x | 1.07x | 0.96x | 0.78x | 0.83x | 0.91x | 0.93x | 0.95x | 0.98x | 0.94x |
Asset Growth % | -13.34% | -6.82% | 15.7% | 12.04% | -2.21% | -1.51% | 1.35% | -2.21% | 0.34% | -17.02% |
Total Current Liabilities | 284.49M | 169.43M | 192.18M | 182.27M | 192.36M | 208.86M | 198.64M | 195.27M | 192.58M | 205.84M |
Accounts Payable | 17.49M | 19.69M | 29.56M | 23.13M | 19.47M | 31.34M | 33.74M | 50.02M | 34.03M | 52.8M |
Days Payables Outstanding | 26.37 | 29.56 | 42.13 | 36.2 | 30.01 | 42.37 | 41.94 | 60.13 | 39.87 | 50.26 |
Short-Term Debt | 113.02M | 0 | 0 | 0 | 3.79M | 8.56M | 5.72M | 7.76M | 12.73M | 19.39M |
Deferred Revenue (Current) | 104.71M | 98.3M | 98.73M | 105.78M | 106.6M | 100.67M | 92.96M | 85.64M | 94.5M | 209.44M |
Other Current Liabilities | 104.71M | 98.3M | 98.73M | 17.96M | 0 | 41.19M | 4.26M | 29.52M | 24.28M | 122.29M |
Current Ratio | 1.09x | 1.68x | 1.79x | 1.96x | 1.83x | 1.68x | 1.70x | 1.66x | 1.65x | 1.42x |
Quick Ratio | 0.72x | 1.04x | 1.16x | 1.22x | 1.18x | 1.00x | 0.97x | 0.95x | 0.92x | 0.66x |
Cash Conversion Cycle | 201.33 | 192.83 | 227.57 | 260.48 | 242.73 | 236.14 | 209.67 | 186.95 | 203.26 | 186.13 |
Total Non-Current Liabilities | 75.44M | 160.66M | 196.13M | 245.02M | 218.9M | 210.8M | 226.92M | 228.28M | 196.49M | 200.05M |
Long-Term Debt | 51.55M | 131.08M | 159.84M | 189.31M | 170.01M | 171.91M | 171.56M | 164.4M | 123.79M | 28.99M |
Capital Lease Obligations | 0 | 0 | 0 | 24.17M | 17.44M | 10.45M | 23.6M | 32.37M | 32.48M | 94.15M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 10.07M | 8.61M | 9.65M | 7.42M | 7.77M | 3.75M | 4.67M | 7.39M | 13.66M | 171.06M |
Total Liabilities | 359.93M | 330.1M | 388.31M | 427.29M | 411.26M | 419.66M | 425.56M | 423.54M | 389.07M | 405.89M |
Total Debt | 164.57M | 131.08M | 159.84M | 221.7M | 199.41M | 199.49M | 205.04M | 210.75M | 176.38M | 48.38M |
Net Debt | 92.49M | 47.99M | 83.05M | 114.13M | 83.04M | 110.75M | 115.63M | 142.18M | 118.96M | 10.31M |
Debt / Equity | 3.54x | 2.70x | 3.21x | 3.48x | 2.90x | 3.75x | 3.82x | 4.67x | 2.17x | 1.16x |
Debt / EBITDA | 20.13x | 22.09x | 274.17x | 11.04x | 6.97x | 14.60x | 29.68x | 32.88x | 12.61x | -7.56x |
Net Debt / EBITDA | 11.31x | 8.09x | 142.45x | 5.68x | 2.90x | 8.11x | 16.74x | 22.18x | 8.50x | -1.61x |
Interest Coverage | -0.65x | -0.54x | 0.04x | 1.31x | 0.73x | 0.75x | 0.36x | -0.02x | 1.09x | -0.54x |
Total Equity | 46.53M▲ 0% | 48.63M▲ 4.5% | 49.87M▲ 2.5% | 63.63M▲ 27.6% | 68.84M▲ 8.2% | 53.19M▼ 22.7% | 53.66M▲ 0.9% | 45.08M▼ 16.0% | 81.17M▲ 80.0% | 41.71M▲ 0% |
Equity Growth % | -22% | 4.51% | 2.55% | 27.6% | 8.18% | -22.74% | 0.88% | -15.98% | 80.04% | 112.5% |
Book Value per Share | 0.56 | 0.57 | 0.57 | 0.70 | 0.75 | 0.58 | 0.57 | 0.46 | 0.79 | 0.34 |
Total Shareholders' Equity | 46.53M | 48.63M | 49.87M | 63.63M | 68.84M | 53.19M | 53.66M | 45.08M | 81.17M | 41.71M |
Common Stock | 84K | 86K | 89K | 91K | 91K | 94K | 97K | 100K | 113K | 119K |
Retained Earnings | -450.39M | -474.29M | -485.54M | -481.71M | -488.02M | -492.52M | -502.14M | -517.68M | -519.27M | -566.52M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -52K | 1.09M | -10K | -484K | 2.09M | 2.41M | 422K | -4.22M | -1.84M | -2.67M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ARAY Cash Flow Statement
Accuray Incorporated (ARAY) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -380K | 18.33M | -29.64M | -1.47M | 38.51M | -2.4M | 15.54M | -11.9M | 2.86M | -19.12M |
Operating CF Margin % | -0.1% | 4.53% | -7.08% | -0.38% | 9.72% | -0.56% | 3.47% | -2.67% | 0.62% | - |
Operating CF Growth % | -101.13% | 4923.95% | -261.7% | 95.04% | 2721.65% | -106.23% | 747.46% | -176.61% | 124.03% | -1049.89% |
Net Income | -29.58M | -23.9M | -16.43M | 3.83M | -6.31M | -5.35M | -9.28M | -15.54M | -1.59M | -46.13M |
Depreciation & Amortization | 18.04M | 9.73M | 10.49M | 7.54M | 6.39M | 5.51M | 4.53M | 5.91M | 6.15M | 7.51M |
Stock-Based Compensation | 13.63M | 12.29M | 10.6M | 8.15M | 9.33M | 10.6M | 10.05M | 9.48M | 10.2M | 6.71M |
Deferred Taxes | -268K | 30K | -86K | 353K | -114K | 1.78M | 456K | 1.4M | 156K | 80K |
Other Non-Cash Items | 10.28M | 10.13M | 12.5M | 538K | 21.42M | 7.65M | 5.16M | 8.77M | 6.15M | 13.44M |
Working Capital Changes | -12.49M | 10.04M | -46.72M | -21.88M | 7.8M | -22.6M | 4.62M | -21.92M | -18.2M | -736K |
Change in Receivables | -15.73M | 7.22M | -46.16M | 19.03M | 5.24M | -12.52M | 18.49M | -15.83M | 13.36M | 12.61M |
Change in Inventory | 7.67M | -8.69M | -14.16M | -23.18M | 1.69M | -22.86M | -6.86M | -4M | -9.11M | -15.11M |
Change in Payables | 2.19M | 2M | 9.46M | -6.77M | -3.98M | 11.68M | 2.85M | 17.36M | -18.67M | 6.78M |
Cash from Investing | 17.82M | 17.77M | -4.31M | -3.73M | -2.4M | -4.72M | -12.68M | -3.6M | -8.52M | -14.33M |
Capital Expenditures | -5.36M | -6.61M | -4.31M | -3.56M | -2.32M | -4.72M | -12.61M | -3.6M | -4.27M | -6.72M |
CapEx % of Revenue | 1.4% | 1.63% | 1.03% | 0.93% | 0.59% | 1.1% | 2.82% | 0.81% | 0.93% | 1.57% |
Acquisitions | 333K | 333K | 0 | 0 | -79K | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -333K | -333K | 0 | -170K | -389K | 0 | -67K | 0 | -4.25M | -7.61M |
Cash from Financing | -54.54M | -27.45M | 28.47M | 26.7M | -28.8M | -15.37M | -2.11M | -3.95M | -4.25M | -2.49M |
Debt Issued (Net) | -56.91M | -31.55M | 24.55M | 24.45M | -17.41M | -19M | -3.87M | -6M | 7.5M | 9.9M |
Equity Issued (Net) | 0 | 0 | 3.93M | 0 | -14.42M | 3.89M | 2.2M | 2.25M | 1.63M | 1.29M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -1.42M | -293K | 0 | 0 | -14.08M | 0 | 0 | 0 | 0 | 0 |
Other Financing | 2.37M | 4.1M | 0 | 2.24M | 3.03M | -258K | -447K | -198K | -13.38M | -13.68M |
Net Change in Cash | -36.9M▲ 0% | 8.3M▲ 122.5% | -5.36M▼ 164.5% | 21.73M▲ 505.8% | 8.29M▼ 61.9% | -28.05M▼ 438.3% | 1.05M▲ 103.7% | -20.81M▼ 2085.7% | -8.26M▲ 60.3% | -35.79M▲ 0% |
Free Cash Flow | -5.74M▲ 0% | 11.72M▲ 304.1% | -33.95M▼ 389.6% | -5.2M▲ 84.7% | 36.19M▲ 796.4% | -7.12M▼ 119.7% | 2.86M▲ 140.2% | -15.51M▼ 642.5% | -5.66M▲ 63.5% | -28.95M▲ 0% |
FCF Margin % | -1.5% | 2.9% | -8.11% | -1.36% | 9.13% | -1.66% | 0.64% | -3.47% | -1.24% | -6.76% |
FCF Growth % | -122.55% | 304.07% | -389.64% | 84.69% | 796.4% | -119.66% | 140.16% | -642.51% | 63.48% | -264.88% |
FCF per Share | -0.07 | 0.14 | -0.39 | -0.06 | 0.39 | -0.08 | 0.03 | -0.16 | -0.06 | -0.23 |
FCF Conversion (FCF/Net Income) | 0.01x | -0.77x | 1.80x | -0.38x | -6.10x | 0.45x | -1.67x | 0.77x | -1.80x | 0.63x |
Interest Paid | 9.93M | 9.19M | 9.76M | 12.33M | 11.89M | 7.46M | 9.85M | 10.52M | 9.74M | 0 |
Taxes Paid | 4.46M | 1.46M | 2.19M | 2.81M | 1.87M | 1.4M | 2.15M | 1.75M | 3.87M | 0 |
ARAY Key Ratios
Accuray Incorporated (ARAY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -55.71% | -50.23% | -33.36% | 6.74% | -9.53% | -8.76% | -17.37% | -31.49% | -2.52% | -77.48% |
Return on Invested Capital (ROIC) | -5.09% | -2.42% | -6.47% | 6.05% | 10.12% | 3.87% | 1.07% | 0.21% | 3.04% | -7.02% |
Gross Margin | 36.86% | 39.93% | 38.84% | 39.1% | 40.25% | 37.21% | 34.4% | 32.01% | 32.05% | 26.81% |
Net Margin | -7.71% | -5.9% | -3.92% | 1% | -1.59% | -1.24% | -2.07% | -3.48% | -0.35% | -10.76% |
Debt / Equity | 3.54x | 2.70x | 3.21x | 3.48x | 2.90x | 3.75x | 3.82x | 4.67x | 2.17x | 1.16x |
Interest Coverage | -0.65x | -0.54x | 0.04x | 1.31x | 0.73x | 0.75x | 0.36x | -0.02x | 1.09x | -0.54x |
FCF Conversion | 0.01x | -0.77x | 1.80x | -0.38x | -6.10x | 0.45x | -1.67x | 0.77x | -1.80x | 0.63x |
Revenue Growth | -3.86% | 5.6% | 3.43% | -8.56% | 3.49% | 8.48% | 4.12% | -0.24% | 2.68% | -7.88% |
Related:ARAY Dividend History·ARAY Revenue History·ARAY Price History·ARAY P/E History·ARAY Financial Ratios·ARAY Institutional Holders
ARAY SEC Filings & Documents
Accuray Incorporated (ARAY) SEC filings — annual & quarterly reports (10-K, 10-Q)
ARAY Frequently Asked Questions
Accuray Incorporated (ARAY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Accuray Incorporated (ARAY) reported $428.6M in revenue for fiscal year 2025. This represents a 1815% increase from $22.4M in 2005.
Accuray Incorporated (ARAY) grew revenue by 2.7% over the past year. Growth has been modest.
Accuray Incorporated (ARAY) reported a net loss of $46.1M for fiscal year 2025.
Dividend & Returns
Accuray Incorporated (ARAY) has a return on equity (ROE) of -2.5%. Negative ROE indicates the company is unprofitable.
Accuray Incorporated (ARAY) had negative free cash flow of $29.0M in fiscal year 2025, likely due to heavy capital investments.